glp-1 and depression Psychotropic effects of GLP-1R agonists New Study: GLP-1s REDUCED Depression

Novo Nordisk is the same company that manufactures Ozempic and Wegovy

In the SURPASS-2 clinical trial, Mounjaro demonstrated greater HbA1c reductions compared to semaglutide 1 mg, with mean reductions of up to 2.3% (25 mmol/mol) from baseline at the 15 mg dose

D.Brigelius-FlohR.DoriaD.van den HeuvelJ.McCarthyJ.et al

More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Drugs.com Podcast Subscribe to our newsletter Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.